Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
59 studies found for:    Open Studies | "Papillomavirus Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Papillomavirus Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Oral Human Papillomavirus Infection in HIV-infected Men
Conditions: Papillomavirus Infections;   HIV Infections
Intervention: Procedure: Oral swabs for HPV-typing and high-risk HPV-determination
2 Recruiting Vaccine Therapy in Preventing Human Papillomavirus Infection in Younger Cancer Survivors
Conditions: Cancer Survivor;   Prevention of Human Papillomavirus Infection
Interventions: Biological: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine or nonavalent human papillomavirus vaccine (HPV 6, 11, 16, 18, 31, 33, 45, 52, 58);   Other: laboratory biomarker analysis;   Other: survey administration;   Other: medical chart review
3 Recruiting Lubricant Investigation in Men to Inhibit Transmission of HPV Infection
Condition: Human Papillomavirus Infection
Interventions: Other: Carrageenan-based gel;   Other: Control gel
4 Unknown  Modeling Study to Predict Progression of Anal Cancer Pre-cursor Lesions in HIV
Conditions: Neoplasms, Squamous Cell;   Papillomavirus Infections
5 Recruiting Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1)
Conditions: Cervical Intraepithelial Neoplasia;   Low-Grade Squamous Intraepithelial Lesions;   Papillomavirus Infections
Interventions: Drug: Aminolaevulinic acid;   Drug: Placebo
6 Not yet recruiting Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix
Conditions: Uterine Cervical Dysplasia;   Papillomavirus Infections
Interventions: Drug: AV2;   Drug: Placebo
7 Recruiting Viral Load Determination and Biomarkers of High Risk Human Papillomavirus (HPV) - Types in HIV-positive Men
Conditions: HIV Infections;   Papillomavirus Infections;   Anal Intraepithelial Neoplasia
Intervention: Behavioral: Smear and biopsy testing for HPV-types and viral load
8 Not yet recruiting Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Conditions: Human Papillomavirus Infection;   Stage I Oral Cavity Squamous Cell Carcinoma;   Stage I Oropharyngeal Squamous Cell Carcinoma;   Stage II Oral Cavity Squamous Cell Carcinoma;   Stage II Oropharyngeal Squamous Cell Carcinoma;   Stage III Oral Cavity Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma
Interventions: Biological: Durvalumab;   Other: Laboratory Biomarker Analysis;   Procedure: Therapeutic Conventional Surgery
9 Recruiting Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
Conditions: Anal Carcinoma;   HIV Infection;   Human Papillomavirus Infection
Interventions: Procedure: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
10 Recruiting Recombinant Human Papillomavirus Nonavalent Vaccine in Preventing Human Papilloma Virus in Younger Healthy Participants
Conditions: Human Papillomavirus Infection;   No Evidence of Disease
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Recombinant Human Papillomavirus Nonavalent Vaccine
11 Recruiting HPV Self-Test Intervention in Ohio Appalachia
Conditions: Cervical Carcinoma;   Human Papillomavirus Infection
Interventions: Procedure: Disease Screening;   Other: Educational Intervention;   Other: Informational Intervention;   Other: Laboratory Biomarker Analysis;   Other: Survey Administration
12 Recruiting Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants
Conditions: Healthy Subject;   Human Papillomavirus Infection
Interventions: Drug: carrageenan-containing gel;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration
13 Recruiting CATCH-UP Intervention in Increasing Cancer Screening and Prevention Care in Uninsured Patients at Community Health Centers
Conditions: Breast Carcinoma;   Cervical Carcinoma;   Colorectal Carcinoma;   Health Status Unknown;   Human Papillomavirus Infection;   Malignant Neoplasm
Intervention: Other: Informational Intervention
14 Recruiting Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study
Condition: Human Papillomavirus Infection
Interventions: Biological: HPV vaccine, Gardasil 9;   Biological: Hepatitis A vaccine
15 Recruiting CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
Conditions: Atypical Endocervical Glandular Cell of Undetermined Significance;   Atypical Endometrial Hyperplasia;   Human Papillomavirus Infection;   Stage 0 Cervical Cancer
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis
16 Recruiting Standard Operating Procedures for Anti-HPV (Human Papillomavirus) Antibody Detection in First-void Urine (AB-SOP Study)
Condition: Human Papilloma Virus Infection
Interventions: Other: First-void urine collection;   Other: Blood draw
17 Recruiting Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx
Interventions: Drug: paclitaxel albumin-stabilized nanoparticle formulation;   Drug: carboplatin;   Radiation: radiation therapy;   Drug: paclitaxel;   Drug: fluorouracil;   Drug: hydroxyurea;   Drug: cisplatin;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
18 Recruiting Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Conditions: Anal Cancer;   High-grade Squamous Intraepithelial Lesion;   HIV Infection;   Human Papilloma Virus Infection
Interventions: Drug: imiquimod;   Drug: fluorouracil;   Procedure: infrared photocoagulation therapy;   Procedure: thermal ablation therapy;   Procedure: laser therapy;   Other: clinical observation;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment
19 Recruiting Community-Driven Cervical Cancer Prevention in Western Kenya
Conditions: Human Papilloma Virus Infection;   Carcinoma in Situ of Uterine Cervix
Interventions: Behavioral: Community-based testing with standard linkage to care;   Behavioral: Community-based HPV testing with enhanced linkage to care
20 Recruiting Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
Conditions: Human Papilloma Virus Infection;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Squamous Cell Carcinoma of the Oropharynx
Interventions: Procedure: therapeutic conventional surgery;   Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Drug: carboplatin;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years